Nuvation Bio (NUVB) Non Operating Income (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Non Operating Income of $1.5 million for Q1 2026, down 73.72% year-over-year from $5.8 million in Q1 2025, and up 159.33% quarter-over-quarter from -$2.6 million in Q4 2025.
Nuvation Bio (NUVB) Non Operating Income (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Non Operating Income for 7 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income fell 73.72% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $4.2 million (down 83.29% YoY), while the FY2025 annual figure was $8.4 million, down 65.83% from the prior year.
- Non Operating Income improved to $1.5 million in Q1 2026 per NUVB's latest filing, from -$2.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at $7.9 million in Q2 2024 and bottomed at -$2.6 million in Q4 2025.
- Historically, Non Operating Income has averaged $4.4 million across 5 years, with a median of $4.8 million in 2023.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 8313.41% — and 2025, when it sank 156.82%.
- Nuvation Bio's Non Operating Income stood at $3.5 million in 2022, then soared by 101.83% to $7.0 million in 2023, then sank by 36.16% to $4.5 million in 2024, then tumbled by 156.82% to -$2.6 million in 2025, then surged by 159.33% to $1.5 million in 2026.
- Business Quant data shows NUVB's Non Operating Income at $1.5 million in Q1 2026, -$2.6 million in Q4 2025, and $642000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | -11.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.80 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | -2.56 Mn |
| Sep 30, 2025 | 642,000.00 |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | 5.77 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | 6.89 Mn |
| Jun 30, 2024 | 7.89 Mn |
| Mar 31, 2024 | 5.41 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Sep 30, 2023 | 6.69 Mn |
| Jun 30, 2023 | 5.49 Mn |
| Mar 31, 2023 | 4.80 Mn |
| Dec 31, 2022 | 3.49 Mn |
| Sep 30, 2022 | 2.14 Mn |
| Jun 30, 2022 | 3.01 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Sep 30, 2021 | 812,000.00 |